Urologic oncologist Ray Tan, MD, provides an overview of prostate cancer treatments and their side effects, and encourages talking through different options to make a shared decision.
Barbara Savoldo, MD, PhD, and Stephanie Wheeler, PhD, MPH, were recently approved as named distinguished professors, one of the highest honors a university bestows to a faculty member.
Dan Reuland, MD, MPH, is the program founder and co-director for the UNC Lineberger Carolina Cancer Screening Initiative, and one of the nation’s leading experts in cancer screening research and implementation.
The UNC Lineberger Patient-Reported Outcomes Center of Excellence recently held its inaugural retreat to discuss the center’s goals and research priorities.
Matthew Nielsen, MD, MS, was selected by the National Academy of Medicine to participate in the 2024 class of the NAM Scholars in Diagnostic Excellence program.
OncLive named Ethan Basch, MD, MSc, FASCO, as one of the 2024 Giants of Cancer Care for his pioneering research in the field of patient-reported outcomes.
UNC and UNC Lineberger researchers and trainees will be presenting talks and participating in scientific and educational panels and discussions on the latest cancer research at the ASCO Annual Meeting.
UNC Lineberger’s Ronny Bell, PhD, MS, is a member of the steering committee that oversaw the development of the American Association for Cancer Research’s Cancer Disparities Progress Report 2024.
Ronny Bell, PhD, MS, has been appointed associate director of Cancer Care Access and Excellence at UNC Lineberger, a role that seeks to end cancer disparities for North Carolinians and beyond.
Kimberly Shoenbill, MD, PhD, MS, and Adam Goldstein, MD, MPH, outline the need for health professionals to work collaboratively to optimize tobacco cessation treatment in patients undergoing lung cancer screening.
Researchers and trainees from UNC and UNC Lineberger at will present more than 30 talks and participate in scientific and educational panels and discussions on the latest cancer research.